Passier et al. generated a transgenic mouse line with overexpression of constitutively active CaMKIV [1] and reported that overexpression of this gene resulted in cardiac hypertrophy and activation of the MEF2 transcription factor in vivo. This evidence concerns the gene CAMK4 and cardiac hypertrophy.